Chang et al. [31] reported that mTOR inhibitors enhance radiosensitivity through inducing apoptosis, reducing autophagy, and suppressing DNA repair proteins in radioresistant prostate cancer cells. The gene discussed is MTOR; the disease is prostate carcinoma.